Balance Sheet for Tiziana Life Sciences plc (TLSA)

$ 6.70   0.28 (+4.36%) Volume: 99.29k 4:00 PM EDT 1-Jul-2020
After Hours:  $ 6.70 0.00 (0.00%) Volume: 19 5:10 PM EDT 1-Jul-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 153 5,304 48 5,803 13,121
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable 84 33 2,092 127 511
Loans Receivable - - - - -
Other Receivables 348 591 115 127 489
Receivables - - - - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 21 33 38 - -
Current Deferred Income Taxes - - - - -
Other Current Assets - 218 293 268 -
Total Current Assets 1,144 6,913 1,596 6,198 13,632
Land and Improvements - - - - -
Buildings and Improvement 329 - - - -
Machinery, Furniture and Equipment 40 46 50 44 -
Construction in Progress - - - - -
Fixed Assets, Other - - (6) - -
Fixed Assets, Total 369 46 44 44 -
Gross Fixed Assets 369 46 44 44 -
Accumulated Depreciation (35) (39) (26) (10) -
Net Fixed Assets 334 7 18 35 -
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 285 217 217 - -
Total Non-Current Assets 664 7 235 35 -
Total Assets 1,808 6,920 1,831 6,232 13,632
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable - - - - -
Short Term Debt 212 - - 278 318
Notes Payable - - - - -
Accrued Expenses - - - - -
Accrued Liabilities - - - - -
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities 5,365 6,401 3,514 1,866 781
Total Current Liabilities 5,577 6,401 3,514 2,143 1,099
Long Term Debt - 520 N/A - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities (130) (520) - - -
Minority Interest - - - - -
Capital Lease Obligations 541 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 411 - - - -
Total Liabilities 5,988 6,401 3,514 2,143 1,099
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity (4,180) 519 (1,683) 4,089 12,533
Common Par 4,099 8,592 3,752 3,494 13,816
Additional Paid in Capital 56,377 81,124 49,296 41,031 30,406
Cumulative Translation Adjustments - - - - -
Retained Earnings (43,146) (50,721) (29,874) (24,858) (18,037)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization (4,180) 1,039 (1,683) 4,089 12,533
Total Equity (4,180) 519 (1,683) 4,089 12,533
Total Liabilities & Shareholder's Equity 1,808 6,920 1,831 6,232 13,632
Cash Flow (9,323) (7,933) (6,359) (9,770) (12,721)
Working Capital (4,433) 512 (1,918) 4,054 12,533
Free Cash Flow (5,328) (4,602) (5,575) (6,974) (8,120)
Invested Capital (4,180) 519 (1,683) 4,089 12,533
Shares Outstanding - Common Class Only 136,655 136,464 125,055 18,879 18,478
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 136,655 136,464 125,055 116,467 136,161
Total Common Shares Outstanding 136,655 136,464 125,055 18,879 18,478
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 136,483 127,554 106,404 23,096 26,893
Diluted Weighted Shares Outstanding 136,483 127,554 106,404 23,096 26,893